Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Continuous fat oxidation in acetyl–CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity
Cheol Soo Choi*,
David B. Savage*,
Lutfi Abu-Elheiga,
Zhen-Xiang Liu*,
Sheene Kim*,
Ameya Kulkarni*,
Alberto Distefano*,
Yu-Jin Hwang*,
Richard M. Reznick*,
Roberto Codella*,
Dongyan Zhang*,
Gary W. Cline*,
Salih J. Wakil,, and
Gerald I. Shulman*,,¶,||
Departments of *Internal Medicine and Cellular and Molecular Physiology and ¶Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06510; and Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030
Contributed by Salih J. Wakil, July 30, 2007 (sent for reviewJune 1, 2007)
Received for publication June 1, 2007.
Abstract:
Acetyl–CoA carboxylase 2 (ACC)2 is a key regulator ofmitochondrial fat oxidation. To examine the impact of ACC2 deletionon whole-body energy metabolism, we measured changes in substrateoxidation and total energy expenditure in Acc2–/–and WT control mice fed either regular or high-fat diets. Todetermine insulin action in vivo, we also measured whole-bodyinsulin-stimulated liver and muscle glucose metabolism duringa hyperinsulinemic–euglycemic clamp in Acc2–/–and WT control mice fed a high-fat diet. Contrary to previousstudies that have suggested that increased fat oxidation mightresult in lower glucose oxidation, both fat and carbohydrateoxidation were simultaneously increased in Acc2–/–mice. This increase in both fat and carbohydrate oxidation resultedin an increase in total energy expenditure, reductions in fatand lean body mass and prevention from diet-induced obesity.Furthermore, Acc2–/– mice were protected from fat-inducedperipheral and hepatic insulin resistance. These improvementsin insulin-stimulated glucose metabolism were associated withreduced diacylglycerol content in muscle and liver, decreasedPKC activity in muscle and PKC activity in liver, and increasedinsulin-stimulated Akt2 activity in these tissues. Taken togetherwith previous work demonstrating that Acc2–/– micehave a normal lifespan, these data suggest that Acc2 inhibitionis a viable therapeutic option for the treatment of obesityand type 2 diabetes.
Author contributions: C.S.C. and D.B.S. contributed equallyto this work; C.S.C., D.B.S., L.A.-E., S.J.W., and G.I.S. designedresearch; C.S.C., Z.-X.L., S.K., A.K., A.D., Y.-J.H., R.M.R.,and D.Z. performed research; C.S.C., D.B.S., L.A.-E., Z.-X.L.,S.K., A.K., A.D., Y.-J.H., R.M.R., R.C., D.Z., G.W.C., S.J.W.,and G.I.S. analyzed data; and C.S.C., D.B.S., L.A.-E., Z.-X.L.,S.K., A.K., A.D., Y.-J.H., R.M.R., R.C., D.Z., G.W.C., S.J.W.,and G.I.S. wrote the paper.
The authors declare no conflict of interest.
To whom correspondence may be addressed. E-mail: swakil{at}bcm.tmc.edu
||To whom correspondence may be addressed at: Yale University School of Medicine, TAC S269, P.O. Box 9812, New Haven, CT 06536-8012. E-mail: gerald.shulman{at}yale.edu
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
L. Bryan Ray (23 October 2007) Sci. STKE2007 (409), tw387.
[DOI: 10.1126/stke.4092007tw387] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
MYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells.
H. Zirath, A. Frenzel, G. Oliynyk, L. Segerstrom, U. K. Westermark, K. Larsson, M. Munksgaard Persson, K. Hultenby, J. Lehtio, C. Einvik, et al. (2013)
PNAS
110, 10258-10263
|Abstract »|Full Text »|PDF »
Retinoic Acid Receptor {beta} Stimulates Hepatic Induction of Fibroblast Growth Factor 21 to Promote Fatty Acid Oxidation and Control Whole-body Energy Homeostasis in Mice.
Y. Li, K. Wong, K. Walsh, B. Gao, and M. Zang (2013)
J. Biol. Chem.
288, 10490-10504
|Abstract »|Full Text »|PDF »
Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr-/- mice.
J. M. Assini, E. E. Mulvihill, B. G. Sutherland, D. E. Telford, C. G. Sawyez, S. L. Felder, S. Chhoker, J. Y. Edwards, R. Gros, and M. W. Huff (2013)
J. Lipid Res.
54, 711-724
|Abstract »|Full Text »|PDF »
AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases: Thematic Review Series: New Lipid and Lipoprotein Targets for the Treatment of Cardiometabolic Diseases.
R. A. K. Srivastava, S. L. Pinkosky, S. Filippov, J. C. Hanselman, C. T. Cramer, and R. S. Newton (2012)
J. Lipid Res.
53, 2490-2514
|Abstract »|Full Text »|PDF »
Germline ablation of VGF increases lipolysis in white adipose tissue.
S. Fargali, T. Scherer, A. C. Shin, M. Sadahiro, C. Buettner, and S. R. Salton (2012)
J. Endocrinol.
215, 313-322
|Abstract »|Full Text »|PDF »
miR-107: a Toll-like receptor-regulated miRNA dysregulated in obesity and type II diabetes.
Cardiac-Specific Deletion of Acetyl CoA Carboxylase 2 Prevents Metabolic Remodeling During Pressure-Overload Hypertrophy.
S. C. Kolwicz Jr, D. P. Olson, L. C. Marney, L. Garcia-Menendez, R. E. Synovec, and R. Tian (2012)
Circ. Res.
111, 728-738
|Abstract »|Full Text »|PDF »
BNip3 Regulates Mitochondrial Function and Lipid Metabolism in the Liver.
D. Glick, W. Zhang, M. Beaton, G. Marsboom, M. Gruber, M. C. Simon, J. Hart, G. W. Dorn II, M. J. Brady, and K. F. Macleod (2012)
Mol. Cell. Biol.
32, 2570-2584
|Abstract »|Full Text »|PDF »
Ventricular Assist Device Implantation Corrects Myocardial Lipotoxicity, Reverses Insulin Resistance, and Normalizes Cardiac Metabolism in Patients With Advanced Heart Failure.
A. Chokshi, K. Drosatos, F. H. Cheema, R. Ji, T. Khawaja, S. Yu, T. Kato, R. Khan, H. Takayama, R. Knoll, et al. (2012)
Circulation
125, 2844-2853
|Abstract »|Full Text »|PDF »
Lipid metabolism in skeletal muscle: generation of adaptive and maladaptive intracellular signals for cellular function.
M. J. Watt and A. J. Hoy (2012)
Am J Physiol Endocrinol Metab
302, E1315-E1328
|Abstract »|Full Text »|PDF »
Phenotypic Discrepancies in Acetyl-CoA Carboxylase 2-deficient Mice.
K. L. Hoehn, N. Turner, G. J. Cooney, and D. E. James (2012)
J. Biol. Chem.
287, 15801
|Full Text »|PDF »
Reply to Hoehn et al.: Phenotypic Discrepancies in Acetyl-CoA Carboxylase 2-deficient Mice.
L. Abu-Elheiga, H. Wu, Z. Gu, and S. J. Wakil (2012)
J. Biol. Chem.
287, 15802
|Full Text »|PDF »
Acetyl-CoA Carboxylase 2-/- Mutant Mice are Protected against Fatty Liver under High-fat, High-carbohydrate Dietary and de Novo Lipogenic Conditions.
L. Abu-Elheiga, H. Wu, Z. Gu, R. Bressler, and S. J. Wakil (2012)
J. Biol. Chem.
287, 12578-12588
|Abstract »|Full Text »|PDF »
Role of Hypothalamic Proopiomelanocortin Neuron Autophagy in the Control of Appetite and Leptin Response.
W. Quan, H.-K. Kim, E.-Y. Moon, S. S. Kim, C. S. Choi, M. Komatsu, Y. T. Jeong, M.-K. Lee, K.-W. Kim, M.-S. Kim, et al. (2012)
Endocrinology
153, 1817-1826
|Abstract »|Full Text »|PDF »
Regulation and limitations to fatty acid oxidation during exercise.
Sustained activation of PPAR{alpha} by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice.
J. Huang, Y. Jia, T. Fu, N. Viswakarma, L. Bai, M. S. Rao, Y. Zhu, J. Borensztajn, and J. K. Reddy (2012)
FASEB J
26, 628-638
|Abstract »|Full Text »|PDF »
Dissociation of Inositol-requiring Enzyme (IRE1{alpha})-mediated c-Jun N-terminal Kinase Activation from Hepatic Insulin Resistance in Conditional X-box-binding Protein-1 (XBP1) Knock-out Mice.
M. J. Jurczak, A.-H. Lee, F. R. Jornayvaz, H.-Y. Lee, A. L. Birkenfeld, B. A. Guigni, M. Kahn, V. T. Samuel, L. H. Glimcher, and G. I. Shulman (2012)
J. Biol. Chem.
287, 2558-2567
|Abstract »|Full Text »|PDF »
Liver-specific Inducible Nitric-oxide Synthase Expression Is Sufficient to Cause Hepatic Insulin Resistance and Mild Hyperglycemia in Mice.
S. Shinozaki, C. S. Choi, N. Shimizu, M. Yamada, M. Kim, T. Zhang, H. H. Dong, Y.-B. Kim, and M. Kaneki (2011)
J. Biol. Chem.
286, 34959-34975
|Abstract »|Full Text »|PDF »
Hepatitis B Virus X Protein Regulates Hepatic Glucose Homeostasis via Activation of Inducible Nitric Oxide Synthase.
H.-J. Shin, Y.-H. Park, S.-U. Kim, H.-B. Moon, D. S. Park, Y.-H. Han, C.-H. Lee, D.-S. Lee, I.-S. Song, D. H. Lee, et al. (2011)
J. Biol. Chem.
286, 29872-29881
|Abstract »|Full Text »|PDF »
CrbpI Modulates Glucose Homeostasis and Pancreas 9-cis-Retinoic Acid Concentrations.
M. A. Kane, A. E. Folias, A. Pingitore, M. Perri, C. R. Krois, J. Y. Ryu, E. Cione, and J. L. Napoli (2011)
Mol. Cell. Biol.
31, 3277-3285
|Abstract »|Full Text »|PDF »
Pigment Epithelium-Derived Factor Regulates Lipid Metabolism via Adipose Triglyceride Lipase.
M. L. Borg, Z. B. Andrews, E. J. Duh, R. Zechner, P. J. Meikle, and M. J. Watt (2011)
Diabetes
60, 1458-1466
|Abstract »|Full Text »|PDF »
SGLT2 Deletion Improves Glucose Homeostasis and Preserves Pancreatic {beta}-Cell Function.
M. J. Jurczak, H.-Y. Lee, A. L. Birkenfeld, F. R. Jornayvaz, D. W. Frederick, R. L. Pongratz, X. Zhao, G. W. Moeckel, V. T. Samuel, J. M. Whaley, et al. (2011)
Diabetes
60, 890-898
|Abstract »|Full Text »|PDF »
Coffee polyphenols suppress diet-induced body fat accumulation by downregulating SREBP-1c and related molecules in C57BL/6J mice.
T. Murase, K. Misawa, Y. Minegishi, M. Aoki, H. Ominami, Y. Suzuki, Y. Shibuya, and T. Hase (2011)
Am J Physiol Endocrinol Metab
300, E122-E133
|Abstract »|Full Text »|PDF »
Inhibition of De Novo Ceramide Synthesis Reverses Diet-Induced Insulin Resistance and Enhances Whole-Body Oxygen Consumption.
J. R. Ussher, T. R. Koves, V. J. J. Cadete, L. Zhang, J. S. Jaswal, S. J. Swyrd, D. G. Lopaschuk, S. D. Proctor, W. Keung, D. M. Muoio, et al. (2010)
Diabetes
59, 2453-2464
|Abstract »|Full Text »|PDF »
Oxidation of intramyocellular lipids is dependent on mitochondrial function and the availability of extracellular fatty acids.
E. Corpeleijn, N. P. Hessvik, S. S. Bakke, K. Levin, E. E. Blaak, G. H. Thoresen, M. Gaster, and A. C. Rustan (2010)
Am J Physiol Endocrinol Metab
299, E14-E22
|Abstract »|Full Text »|PDF »
Progressive adaptation of hepatic ketogenesis in mice fed a high-fat diet.
N. E. Sunny, S. Satapati, X. Fu, T. He, R. Mehdibeigi, C. Spring-Robinson, J. Duarte, M. J. Potthoff, J. D. Browning, and S. C. Burgess (2010)
Am J Physiol Endocrinol Metab
298, E1226-E1235
|Abstract »|Full Text »|PDF »
Recombinant yeast screen for new inhibitors of human acetyl-CoA carboxylase 2 identifies potential drugs to treat obesity.
J. Marjanovic, D. Chalupska, C. Patenode, A. Coster, E. Arnold, A. Ye, G. Anesi, Y. Lu, I. Okun, S. Tkachenko, et al. (2010)
PNAS
107, 9093-9098
|Abstract »|Full Text »|PDF »
Gene knockout of Acc2 has little effect on body weight, fat mass, or food intake.
D. P. Olson, T. Pulinilkunnil, G. W. Cline, G. I. Shulman, and B. B. Lowell (2010)
PNAS
107, 7598-7603
|Abstract »|Full Text »|PDF »
Mice Lacking Hepatic Lipase Are Lean and Protected against Diet-Induced Obesity and Hepatic Steatosis.
H. K. Chiu, K. Qian, K. Ogimoto, G. J. Morton, B. E. Wisse, N. Agrawal, T. O. McDonald, M. W. Schwartz, and H. L. Dichek (2010)
Endocrinology
151, 993-1001
|Abstract »|Full Text »|PDF »
Myocardial Fatty Acid Metabolism in Health and Disease.
G. D. Lopaschuk, J. R. Ussher, C. D. L. Folmes, J. S. Jaswal, and W. C. Stanley (2010)
Physiol Rev
90, 207-258
|Abstract »|Full Text »|PDF »
PGC-1{alpha} negatively regulates hepatic FGF21 expression by modulating the heme/Rev-Erb{alpha} axis.
J. L. Estall, J. L. Ruas, C. S. Choi, D. Laznik, M. Badman, E. Maratos-Flier, G. I. Shulman, and B. M. Spiegelman (2009)
PNAS
106, 22510-22515
|Abstract »|Full Text »|PDF »
Ubiquitin C-terminal hydrolase-L3-knockout mice are resistant to diet-induced obesity and show increased activation of AMP-activated protein kinase in skeletal muscle.
R. Setsuie, M. Suzuki, T. Kabuta, H. Fujita, S. Miura, N. Ichihara, D. Yamada, Y.-L. Wang, O. Ezaki, Y. Suzuki, et al. (2009)
FASEB J
23, 4148-4157
|Abstract »|Full Text »|PDF »
Insulin Resistance and Altered Systemic Glucose Metabolism in Mice Lacking Nur77.
L. C. Chao, K. Wroblewski, Z. Zhang, L. Pei, L. Vergnes, O. R. Ilkayeva, S. Y. Ding, K. Reue, M. J. Watt, C. B. Newgard, et al. (2009)
Diabetes
58, 2788-2796
|Abstract »|Full Text »|PDF »
The Randle cycle revisited: a new head for an old hat.
L. Hue and H. Taegtmeyer (2009)
Am J Physiol Endocrinol Metab
297, E578-E591
|Abstract »|Full Text »|PDF »
Insulin-Stimulated Cardiac Glucose Oxidation Is Increased in High-Fat Diet-Induced Obese Mice Lacking Malonyl CoA Decarboxylase.
J. R. Ussher, T. R. Koves, J. S. Jaswal, L. Zhang, O. Ilkayeva, J. R.B. Dyck, D. M. Muoio, and G. D. Lopaschuk (2009)
Diabetes
58, 1766-1775
|Abstract »|Full Text »|PDF »
Fibroblast Growth Factor-19, a Novel Factor That Inhibits Hepatic Fatty Acid Synthesis.
S. Bhatnagar, H. A. Damron, and F. B. Hillgartner (2009)
J. Biol. Chem.
284, 10023-10033
|Abstract »|Full Text »|PDF »
Fatty acid metabolism: target for metabolic syndrome.
Overexpression of Carnitine Palmitoyltransferase-1 in Skeletal Muscle Is Sufficient to Enhance Fatty Acid Oxidation and Improve High-Fat Diet-Induced Insulin Resistance.
C. R. Bruce, A. J. Hoy, N. Turner, M. J. Watt, T. L. Allen, K. Carpenter, G. J. Cooney, M. A. Febbraio, and E. W. Kraegen (2009)
Diabetes
58, 550-558
|Abstract »|Full Text »|PDF »
Increased Energy Expenditure and Insulin Sensitivity in the High Bone Mass {Delta}FosB Transgenic Mice.
G. C. Rowe, C. S. Choi, L. Neff, W. C. Horne, G. I. Shulman, and R. Baron (2009)
Endocrinology
150, 135-143
|Abstract »|Full Text »|PDF »
Skeletal Muscle-Specific Deletion of Lipoprotein Lipase Enhances Insulin Signaling in Skeletal Muscle but Causes Insulin Resistance in Liver and Other Tissues.
H. Wang, L. A. Knaub, D. R. Jensen, D. Young Jung, E.-G. Hong, H.-J. Ko, A. M. Coates, I. J. Goldberg, B. A. de la Houssaye, R. C. Janssen, et al. (2009)
Diabetes
58, 116-124
|Abstract »|Full Text »|PDF »
Paradoxical effects of increased expression of PGC-1{alpha} on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism.
C. S. Choi, D. E. Befroy, R. Codella, S. Kim, R. M. Reznick, Y.-J. Hwang, Z.-X. Liu, H.-Y. Lee, A. Distefano, V. T. Samuel, et al. (2008)
PNAS
105, 19926-19931
|Abstract »|Full Text »|PDF »
AMP Activated Protein Kinase-{alpha}2 Deficiency Exacerbates Pressure-Overload-Induced Left Ventricular Hypertrophy and Dysfunction in Mice.
P. Zhang, X. Hu, X. Xu, J. Fassett, G. Zhu, B. Viollet, W. Xu, B. Wiczer, D. A. Bernlohr, R. J. Bache, et al. (2008)
Hypertension
52, 918-924
|Abstract »|Full Text »|PDF »
The malonyl CoA axis as a potential target for treating ischaemic heart disease.
Reduced heart size and increased myocardial fuel substrate oxidation in ACC2 mutant mice.
M. F. Essop, H. S. Camp, C. S. Choi, S. Sharma, R. M. Fryer, G. A. Reinhart, P. H. Guthrie, A. Bentebibel, Z. Gu, G. I. Shulman, et al. (2008)
Am J Physiol Heart Circ Physiol
295, H256-H265
|Abstract »|Full Text »|PDF »
Setting the stage: possible mechanisms by which acute contraction restores insulin sensitivity in muscle.
J. P. Thyfault (2008)
Am J Physiol Regulatory Integrative Comp Physiol
294, R1103-R1110
|Abstract »|Full Text »|PDF »